Novel sample preparation technology identified as an important innovation for company’s cancer screening tests, and for external clinicians and researchers. (Aug. 11, 2017) Click to view
Company takes critical step in the commercialization of its PWS Nanocytology cancer screening technology platform. (Aug. 3, 2017) Click to view
On its Engineering News web page, Northwestern University’s McCormick School of Engineering posted two videos and a news story that reported, “Vadim Backman’s new screening technologies hold promise for dramatic changes in the diagnosis and treatment of cancer.” (Sept. 29, 2016) Cick to view.
In the first episode of its “Amazing Things” podcast series, the national United for Medical Research coalition featured Northwestern Professor and Preora Chairman Vadim Backman, who explains why PWS Nanocytology is a breakthrough method for detecting cancer earlier than ever. (Sept. 13, 2016) Click to view
The Wall Street Journal (June 26, 2016) highlighted our screening tests as an emerging technology that “could have a big impact on medicine in the coming years.” (June 26, 2016) Click to view.
Preora President and CEO John W. Hart will participate in the prestigious “Innovation Showcase” at AdvaMed 2015 on October 7. Click here to read more. Preora to Present at AdvaMed_09.10.15
NanoCytomics LLC today announced the formation of Preora Diagnostics Inc., a privately held medical technology company that will bring low-cost cancer pre-screening tests to primary care physicians in the U.S. and other select markets. Click here to learn more. Preora Launch Release . Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut maximus imperdiet leo, non mattis neque laoreet [Continue Reading]
MATTER, Chicago’s new entrepreneurship and innovation hub for next-generation health IT, medical device, diagnostics and biopharma companies, has named NanoCytomics as an early member of its expanding community. Click here to read MATTER’s news release.
White City News Posts Interview with NanoCytomics President John W. Hart On the day of the July 17 announcement of John Hart joining NanoCytomics as president, and again as the lead story in its July 21 weekly news roundup, White City News profiled John W. Hart in an exclusive interview with the influential Chicago life sciences blog. Click here to read story.
NanoCytomics President John Hart brings to the company 35 years of experience in various healthcare sectors, including more than two decades at Baxter International, Allegiance and Cardinal Health. Click here to read full story.
